Literature DB >> 23450112

Imaging techniques as predictive and prognostic biomarkers in renal cell carcinoma.

Paul Nathan1, Anup Vinayan.   

Abstract

A number of imaging modalities are showing promise as predictive and prognostic biomarkers in advanced renal cell carcinoma. This review discusses progress to date in this exciting area and identifies areas of future promise.

Entities:  

Keywords:  biomarkers; imaging; prediction; prognosis; renal cell carcinoma

Year:  2013        PMID： 23450112      PMCID： PMC3556873          DOI： 10.1177/1758834012463624

Source DB:  PubMed          Journal:  Ther Adv Med Oncol        ISSN： 1758-8340            Impact factor:   8.168


  59 in total

1.  Pharmacodynamic study using FLT PET/CT in patients with renal cell cancer and other solid malignancies treated with sunitinib malate.

Authors:  Glenn Liu; Robert Jeraj; Matt Vanderhoek; Scott Perlman; Jill Kolesar; Michael Harrison; Urban Simoncic; Jens Eickhoff; Lakeesha Carmichael; Bo Chao; Rebecca Marnocha; Percy Ivy; George Wilding
Journal:  Clin Cancer Res       Date:  2011-10-28       Impact factor: 12.531

2.  A scoring algorithm to predict survival for patients with metastatic clear cell renal cell carcinoma: a stratification tool for prospective clinical trials.

Authors:  Bradley C Leibovich; John C Cheville; Christine M Lohse; Horst Zincke; Igor Frank; Eugene D Kwon; Jaime R Merchan; Michael L Blute
Journal:  J Urol       Date:  2005-11       Impact factor: 7.450

3.  Multiphase contrast-enhanced helical CT of liver metastases from renal cell carcinoma.

Authors:  V D Raptopoulos; S P Blake; K Weisinger; M B Atkins; M T Keogan; J B Kruskal
Journal:  Eur Radiol       Date:  2001-04-18       Impact factor: 5.315

4.  Sarcomatoid renal cell carcinoma: biologic behavior, prognosis, and response to combined surgical resection and immunotherapy.

Authors:  T Cangiano; J Liao; J Naitoh; F Dorey; R Figlin; A Belldegrun
Journal:  J Clin Oncol       Date:  1999-02       Impact factor: 44.544

Review 5.  The Heidelberg classification of renal cell tumours.

Authors:  G Kovacs; M Akhtar; B J Beckwith; P Bugert; C S Cooper; B Delahunt; J N Eble; S Fleming; B Ljungberg; L J Medeiros; H Moch; V E Reuter; E Ritz; G Roos; D Schmidt; J R Srigley; S Störkel; E van den Berg; B Zbar
Journal:  J Pathol       Date:  1997-10       Impact factor: 7.996

6.  Dynamic contrast-enhanced magnetic resonance imaging pharmacodynamic biomarker study of sorafenib in metastatic renal carcinoma.

Authors:  Olwen M Hahn; Cheng Yang; Milica Medved; Gregory Karczmar; Emily Kistner; Theodore Karrison; Elizabeth Manchen; Myrosia Mitchell; Mark J Ratain; Walter M Stadler
Journal:  J Clin Oncol       Date:  2008-10-01       Impact factor: 44.544

7.  Magnetic resonance imaging-measured blood flow change after antiangiogenic therapy with PTK787/ZK 222584 correlates with clinical outcome in metastatic renal cell carcinoma.

Authors:  Cedric de Bazelaire; David C Alsop; Daniel George; Ivan Pedrosa; Yongyu Wang; M Dror Michaelson; Neil M Rofsky
Journal:  Clin Cancer Res       Date:  2008-09-01       Impact factor: 12.531

8.  Comparison of whole-body MRI and bone scintigraphy in the detection of bone metastases in renal cancer.

Authors:  S A Sohaib; G Cook; S D Allen; M Hughes; T Eisen; M Gore
Journal:  Br J Radiol       Date:  2009-02-16       Impact factor: 3.039

9.  CT perfusion for the monitoring of neoadjuvant chemotherapy and radiation therapy in rectal carcinoma: initial experience.

Authors:  Massimo Bellomi; Giuseppe Petralia; Angelica Sonzogni; Maria Giulia Zampino; Andrea Rocca
Journal:  Radiology       Date:  2007-08       Impact factor: 11.105

10.  Tumor perfusion assessed by dynamic contrast-enhanced MRI correlates to the grading of renal cell carcinoma: initial results.

Authors:  Moritz Palmowski; Isabel Schifferdecker; Stefan Zwick; Stephan Macher-Goeppinger; Hendrik Laue; Axel Haferkamp; Hans-Ulrich Kauczor; Fabian Kiessling; Peter Hallscheidt
Journal:  Eur J Radiol       Date:  2009-06-21       Impact factor: 3.528
View more
  2 in total

1.  The prognostic and predictive value of vascular response parameters measured by dynamic contrast-enhanced-CT, -MRI and -US in patients with metastatic renal cell carcinoma receiving sunitinib.

Authors:  John M Hudson; Colleen Bailey; Mostafa Atri; Greg Stanisz; Laurent Milot; Ross Williams; Alex Kiss; Peter N Burns; Georg A Bjarnason
Journal:  Eur Radiol       Date:  2018-01-30       Impact factor: 5.315

2.  Dynamic contrast-enhanced and diffusion-weighted magnetic resonance imaging noninvasive evaluation of vascular disrupting treatment on rabbit liver tumors.

Authors:  Haibo Shao; Yicheng Ni; Jian Zhang; Feng Chen; Xu Dai; Guoguang Fan; Ziping Sun; Ke Xu
Journal:  PLoS One       Date:  2013-12-23       Impact factor: 3.240
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.